Journal of Viral Hepatitis

Primary hepatocytes as targets for Hepatitis C virus replication
pp. 849-854(6)
Authors: Farquhar, M. J.; McKeating, J. A.

Natural killer cells suppress full cycle HCV infection of human hepatocytes
pp. 855-864(10)
Authors: Wang, S.-H.; Huang, C.-X.; Ye, L.; Wang, X.; Song, L.; Wang, Y.-J.; Liang, H.; Huang, X.-Y.; Ho, W.-Z.

Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor
pp. 865-870(6)
Authors: Régeard, M.; Trotard, M.; Lepère, C.; Gripon, P.; Le Seyec, J.

Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations
pp. 871-877(7)
Authors: Brant, L. J.; Ramsay, M. E.; Balogun, M. A.; Boxall, E.; Hale, A.; Hurrelle, M.; Kaluba, L.; Klapper, P.; Lewis, D.; Patel, B. C.; Parry, J.; Irving, W. L.

Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus
pp. 878-887(10)
Authors: Castaneda-Sceppa, C.; Bermudez, O. I.; Wanke, C.; Forrester, J. E.

Characterization of the innate immune signalling pathways in hepatocyte cell lines
pp. 888-900(13)
Authors: Preiss, S.; Thompson, A.; Chen, X.; Rodgers, S.; Markovska, V.; Desmond, P.; Visvanathan, K.; Li, K.; Locarnini, S.; Revill, P.

The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis
pp. 901-909(9)
Authors: Kennedy, P. T. F.; Gehring, A. J.; Nowbath, A.; Selden, C.; Quaglia, A.; Dhillon, A.; Dusheiko, G.; Bertoletti, A.

Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E
pp. 910-916(7)
Authors: Srivastava, R.; Aggarwal, R.; Bhagat, M. R.; Chowdhury, A.; Naik, S.

Kinetics of hepatitis B virus load and haemodialysis: a prospective study
pp. 917-921(5)
Authors: Fabrizi, F.; Lunghi, G.; Alongi, G.; Aucella, F.; Barbisoni, F.; Bisegna, S.; Corghi, E.; Faranna, P.; Mangano, S.; Romei-Longhena, G.; Martin, P.

Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine
pp. 922-924(3)
Authors: Viganò, M.; Lampertico, P.; Facchetti, F.; Lunghi, G.; Colombo, M.